Press Release: Omeros : Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint

Newly Completed Sensitivity Analyses Demonstrate Robustness of Previously Announced Survival Superiority Over External Control in Patients with TA-TMA Sensitivity analyses support the results of the primary endpoint analysis, with representative...